58. Hypertrophic cardiomyopathy Clinical trials / Disease details

Clinical trials : 126 / Drugs : 135 - (DrugBank : 42) / Drug target genes : 46 - Drug target pathways : 162

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02948998 (ClinicalTrials.gov)	May 14, 2018	27/10/2016	Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy	Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy-- a Multicenter Randomized Control Trial	Hypertrophic Cardiomyopathy;Fibrosis	Drug: Spironolactone	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	Ruijin Hospital;RenJi Hospital;Shanghai Jiao Tong University Affiliated Sixth People's Hospital	Unknown status	18 Years	75 Years	All	260	Phase 4	China
2	NCT00879060 (ClinicalTrials.gov)	November 2007	8/4/2009	Clinical and Therapeutic Implications of Fibrosis in Hypertrophic Cardiomyopathy	Clinical and Therapeutic Implications of Fibrosis in Hypertrophic	Myocardial Fibrosis;Hypertrophic Cardiomyopathy	Drug: spironolactone	Tufts Medical Center	NULL	Recruiting	18 Years	70 Years	Both	95	Phase 4	United States